Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001376043-26-000010
Filing Date
2026-06-16
Accepted
2026-06-16 16:46:48
Documents
1
Period of Report
2026-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06162026_080644.html 4  
1 form4-06162026_080644.xml 4 7598
  Complete submission text file 0001376043-26-000010.txt   9416
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address
Coughlin Timothy (Reporting) CIK: 0001376043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 261095384

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)